Abstract
The currently ongoing Epidemiological Strategy and Medical Economics (ESME) research programme aims at centralising real-life data on oncology care for epidemiological research purposes. We draw on results from the metastatic breast cancer (MBC) cohort to illustrate the methodology used for data collection in the ESME research programme. All consecutive ≥18 years patients with MBC treatment initiated between 2008 and 2014 in one of the 18 French Comprehensive Cancer Centres were selected. Diagnostic, therapeutic and follow-up data (demographics, primary tumour, metastatic disease, treatment patterns and vital status) were collected through the course of the disease. Data collection is updated annually. With a recruitment target of 30 000 patients with MBC by 2019, we currently screened a total of 45 329 patients, and >16 700 patients with a metastatic disease treatment initiated after 2008 have been selected. 20.7% of patients had an hormone receptor (HR)-negative MBC, 73.7% had a HER2-negative MBC and 13.9% were classified as triple-negative BC (ie, HER2 and HR status both negative). Median follow-up duration from MBC diagnosis was 48.55 months for the whole cohort. These real-world data will help standardise the management of...Continue Reading
Citations
Aug 22, 2020·Yearbook of Medical Informatics·Xosé M Fernández
Sep 8, 2020·BMC Cancer·Alison DavieXavier Pivot
May 16, 2019·International Journal of Cancer. Journal International Du Cancer·William JacotAudrey Mailliez
Jan 23, 2020·BMC Cancer·Chris TwelvesTim Perren
Aug 3, 2020·Fundamental & Clinical Pharmacology·Emilie CasarottoMathieu Molimard
Dec 12, 2020·The Breast : Official Journal of the European Society of Mastology·Khalil SalehElise Deluche
Nov 12, 2020·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Paul CottuXavier Pivot
Feb 10, 2021·The Breast : Official Journal of the European Society of Mastology·Luc CabelFlorence Lerebours
Apr 18, 2021·NPJ Breast Cancer·Thomas GrindaMagali Lacroix-Triki
Apr 26, 2021·ESMO Open·T GrindaS Delaloge
May 8, 2020·The Breast : Official Journal of the European Society of Mastology·Sophie FrankPaul Cottu
May 14, 2021·ESMO Open·M CarausuL Cabel
Jul 24, 2021·Gynecologic Oncology·Alexandre De NonnevilleRenaud Sabatier
Jul 26, 2021·ESMO Open·D DanoA Gonçalves
Sep 16, 2021·PloS One·Monia EzzalfaniUNKNOWN ESME Group
May 20, 2021·Breast Care·Diana LüftnerPeter A Fasching